With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Restoring RUNX1 Levels in FPD/AML||University of Washington, Seattle / Marshall Horwitz, MD/PhD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||Washington|
|Identifying Therapeutic Targets to Prevent Progression of Familial RUNX1 Disorder to AML Using Novel iPSC Models||Icahn School of Medicine at Mount Sinai / Eirini Papapetrou, MD/PhD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||New York|
|A Nurse-Led Structured Discharge Teaching Intervention for Parents of Newly Diagnosed Pediatric Oncology Patients||University of Alabama at Birmingham / Wendy Landier, RN/PhD||Nurse Researcher Grants||2016||Alabama|
|Role of Kindlin-3 In Natural Killer Cell Mediated Tumor Killing||Children’s Hospital of Wisconsin - Milwaukee / Nathan Schloemer, MD||Young Investigator Grants||2016||Wisconsin|
|LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma||University of Virginia, School of Medicine / Michael Engel, MD/PhD||Reach Grants||2016||Virginia|
|An Engineered Nanoimmunotherapy for Treating Neuroblastoma||George Washington University / Rohan Fernandes, PhD||'A' Award Grants||2016||District of Columbia|
|Selective Epigenetic Regulation of Notch1 in T-cell Acute Lymphoblastic Leukemia||University of Michigan / Mark Yat-Fung Chiang, MD/PhD||Innovation Grants||2016||Michigan|
|HOX Genes As Developmental Regulators Of Sarcomagenesis||University of Michigan / Elizabeth Lawlor, MD/PhD & Deneen Wellik, PhD||Innovation Grants||2016||Michigan|
|GeneEditing in T cell Leukemia to Promote Immunomodulatory Forms of Cell Death||Boston Children’s Hospital / Dr. Ben Croker, PhD||Innovation Grants||2016||Massachusetts|
|Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML||Boston Children’s Hospital / Alan Cantor, MD, PhD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||Massachusetts|